User:Mr. Ibrahem/Remifentanil

Remifentanil, sold under the brand name Ultiva among others, is an opioid medication used to treat during anesthesia to manage pain. It is given by injection into a vein. Effects begin within 90 seconds and last up to 15 minutes.

Common side effects include respiratory depression (decreased breathing), slow heart rate, low blood pressure, stiff muscles, nausea, and itchiness. Breastfeeding is not recommended for 24 hours after use. It works by activating the mu opioid receptor.

Remifentanil was approved for medical use in the United States in 1996. It is available as a generic medication. In the United Kingdom 1 mg costs the NHS about £5 as of 2021. In the United States this amount costs about 55 USD. In the United States it is classified as a Schedule II controlled substance.